top of page

Independent Broker Tactics for Life Insurance With Multiple Sclerosis

Writer: Jib Hunt
Jib Hunt
Sep 19
10 min read

Adviser reviewing MS coverage options with client

Yes, most people with multiple sclerosis can get life insurance, and the outcome usually depends on one thing: documented stability. Underwriters weigh your Expanded Disability Status Scale score, how long it’s been since your last relapse, and how consistent your treatment has been. The pathways range from fully underwritten term policies for stable, mild cases to simplified-issue and guaranteed products for more complicated ones. Applying right after a relapse or a medication switch is the single most common reason applications get postponed.

 

TL;DR:  
  • Applicants with an EDSS score below 3.0 and several years of documented stability typically qualify for the most favorable underwriting outcomes.

  • Term policies are usually best for stable, mild MS, especially with full underwriting available for those in their 30s or 40s with remission over many years.

  • Waiting at least two years after a relapse or medication change enhances approval chances, as applications made sooner are often postponed or declined.

  • Simplified-issue or guaranteed policies serve as backup options if full underwriting results in high premiums or declines, but face amounts are limited.

  • Working with an independent broker to pre-shop cases anonymously can help identify carriers most likely to approve coverage with favorable terms.

 



Table of Contents

 

 

What Types of Life Insurance Work Best With MS?

 

The right policy type depends less on the MS diagnosis itself and more on where you are in your disease course. Someone five years past their last relapse with an Expanded Disability Status Scale score under 2.0 has very different options than someone recently diagnosed with a progressive form.

 

Term life insurance is usually the most affordable route when MS is mild, stable, and well documented. Terms typically run 10, 20, or 30 years, and most policies include a conversion option that lets you switch to permanent coverage later without new medical underwriting. For someone in their 30s or 40s with relapsing-remitting MS in remission for several years, term coverage through full underwriting is often realistic and reasonably priced.

 

Whole life and other permanent policies make sense when you want coverage that never expires or when the cash-value component matters to your broader financial picture. The tradeoff is cost and underwriting difficulty. Permanent products tend to scrutinize long-term risk more heavily than term policies, so someone with a more active disease course may face steeper ratings here than on a comparable term policy.

 

Simplified-issue and accelerated-underwriting products skip the paramedical exam and rely on a health questionnaire and sometimes a records check instead of a full attending physician statement. These work well for applicants who want speed over the lowest possible price, but face amounts are capped, often somewhere between $25,000 and $500,000 depending on the carrier.

 

Guaranteed-issue and graded-benefit policies exist as a safety net, not a first choice. Guaranteed issue asks no medical questions at all but caps coverage low and delays full death benefit payout for two to three years. Graded-benefit products work similarly but may ask a handful of health questions in exchange for slightly better pricing.

 

Employer or group life insurance deserves a mention because it often bypasses individual medical underwriting entirely. If your employer offers group life as a benefit, that coverage typically doesn’t ask about your MS at all, which makes it a smart layer to secure early, even while you’re shopping for a personal policy.

 

  • Term life: best value for stable, mild MS

  • Whole life: lifetime coverage, higher cost, tougher underwriting

  • Simplified issue: faster, capped face amounts

  • Guaranteed/graded issue: last resort, waiting periods apply

  • Group/employer coverage: usually no individual underwriting

 

How Do Insurers Evaluate an MS Diagnosis?

 

Underwriters don’t treat MS as a single risk category. They build a picture from several specific data points, and each one moves the needle in a different direction.

 

EDSS score and functional status carry significant weight because they measure how the disease is actually affecting your body, not just what type of MS you have. An applicant with an EDSS score below 3.0, meaning minimal disability and full ambulatory ability, tends to see far better offers than someone with significant mobility limitations, regardless of subtype.

 

Time since your last relapse is arguably the most influential factor of all. Carrier underwriting guidance shows real thresholds in action: applications submitted within two years of an attack are often postponed outright, while cases between two and ten years since the last attack tend to receive various table ratings depending on how much impairment remains. Beyond that window, with minimal residual disability, some applicants qualify at standard, non-rated pricing.

 

Underwriting snapshot: Applicants with an EDSS score under 3.0 and several years of documented stability since their last relapse often land the most competitive offers available to people with MS, according to carrier underwriting patterns.

 

Disease subtype matters, but not as much as most people assume. Relapsing-remitting MS in remission usually underwrites better than primary or secondary progressive forms, mainly because progressive MS tends to show a steadier decline in function that’s harder for underwriters to price confidently.

 

Treatment history tells its own story. Consistent adherence to a disease-modifying therapy signals disease management, while a recent switch in medication can look, from an underwriter’s chair, like a sign that the current treatment stopped working. Immune-suppressant drugs sometimes trigger additional questions about infection risk.

 

Medical evidence insurers request typically includes:

 

  • An Attending Physician Statement (APS) from your neurologist

  • Recent MRI reports showing lesion activity or stability

  • A complete medication list with start and change dates

  • Records of relapses, hospitalizations, and ER visits

 

Because MS varies so much from one patient to the next, insurers lean heavily on this specialist documentation rather than the diagnosis code alone. The final decision usually falls into one of four buckets: standard rates, a rated policy with higher premiums, a postponed decision pending more stability, or in rarer cases, a decline.

 

How Should You Prepare Before Applying?

 

Getting organized before you submit an application saves you from the worst outcome in this process: a formal decline that then follows you to every future application. A little preparation upfront changes the odds substantially.

 

  1. Gather your full medical file first. This means your exact diagnosis date, neurologist’s contact information, the most recent APS if you have one on file, MRI reports from the last one to two years, a complete medication history, and dates of any relapses or hospitalizations.

  2. Check your timing. If you’ve had a relapse or changed medications in the last one to two years, experts generally advise waiting until your disease course looks stable on paper before applying. Submitting too soon is the fastest way to get postponed.

  3. Work with a broker who handles pre-existing conditions. An independent broker can anonymize your case details and shop it across multiple carriers before you commit to a formal application, which avoids racking up declines on your record with each carrier that already prices MS conservatively.

  4. Expect a paramedical exam for fully underwritten policies. It’s a short in-home or clinic visit involving blood pressure, blood and urine samples, and basic vitals. Labs handling this kind of medical screening are part of a broader underwriting testing process that most carriers rely on for full underwriting cases.

  5. Plan for a longer timeline. APS requests alone often take several weeks, since your neurologist’s office has to pull and send records. Combined with the carrier’s own review, six to ten weeks from application to decision is common for MS cases.

 

Pro Tip: Ask your broker to pre-shop your case anonymously with two or three carriers before filing a formal application. It costs you nothing and can reveal which company’s underwriting team is friendliest to your specific EDSS score and relapse timeline, before your name is attached to a decision.

 

What Rates and Outcomes Should You Expect?

 

Rate classes for MS applicants rarely land at the extremes. Very few stable, mild cases get declined outright, and very few severe cases get standard pricing. Most land somewhere in a graded middle ground called a “table rating,” where premiums are increased by a set percentage above standard rates rather than a flat dollar surcharge.

 

Here’s how that plays out across severity levels, treated as illustrative ranges rather than guarantees:

 

  • Mild, stable RRMS (EDSS under 2.0, multiple years since last relapse): often qualifies for standard or lightly rated term coverage

  • Moderate MS with occasional relapses or a recent treatment adjustment: commonly falls into a table rating, with premiums notably higher than standard rates

  • Progressive MS with meaningful mobility limitations: frequently faces higher loadings, longer postponement periods, or a decline from fully underwritten carriers

 

A rated offer or a decline isn’t the end of the road. If a carrier comes back with a heavy rating, the first move is usually an appeal with additional records, particularly a fresh APS or updated MRI showing continued stability. If that doesn’t move the needle, simplified-issue or guaranteed-issue products become the practical fallback. And if you have access to group coverage through work, that’s worth securing regardless of what happens with your individual application.

 

Waiting periods matter here too. If you’re postponed, ask the carrier what specific milestone they need to see, whether that’s six more months without a relapse or one more clean MRI, so you’re not reapplying blind.

 

What Backup Options Exist if Full Underwriting Doesn’t Work?

 

Full underwriting isn’t the only door. If your MS is more advanced or your timing simply isn’t right yet, several fallback products exist specifically for situations like this.

 

  • Guaranteed-issue whole life: no medical questions at all, but face amounts are typically capped in the low tens of thousands, and a two- to three-year graded period usually applies before the full death benefit is payable.

  • Graded-benefit policies: similar structure to guaranteed issue, but with a short health questionnaire in exchange for somewhat better pricing than a pure guaranteed-issue product.

  • Simplified-issue, no-exam coverage: no paramedical exam required, faster approval, but face amounts are still limited and pricing sits above what full underwriting would offer a healthy applicant.

  • Employer or group life: often the fastest and cheapest coverage available since most group plans skip individual medical underwriting entirely, making it a smart layer to combine with a personal policy.

 

A common strategy is layering: secure group coverage through work immediately, add a guaranteed or graded policy for a baseline of personal coverage, then revisit full underwriting once your disease course has been stable for a longer stretch. Our guide on impaired-risk life insurance breaks down how that evidence-building process works in more detail.

 

An Independent Adviser’s View on Getting Covered With MS

 

Most of the frustration people with MS feel about life insurance comes from applying too early and treating every carrier’s rules as universal. They’re not. One company’s underwriting desk might postpone a case that another prices at a modest table rating, because internal guidelines on EDSS thresholds and relapse windows genuinely differ from carrier to carrier.


Illustration of varied carrier underwriting outcomes

Working with clients on pre-existing conditions has reinforced one lesson above all others: shopping a case anonymously before filing a formal application beats guessing which carrier will say yes. A broker who understands how different insurers treat pre-existing health conditions can steer an application toward the desk most likely to approve it fairly, rather than letting a client collect declines one carrier at a time.

 

The other piece people underestimate is disclosure. Leaving out a relapse or downplaying a medication change might feel like it improves your odds, but it puts your beneficiaries’ claim at risk years down the road if the carrier later finds the gap. Full, honest disclosure paired with strong documentation is what actually gets favorable underwriting, not omission.

 

— Jib Hunt

 

Get Help Finding the Right MS-Friendly Policy

 

The firm works as an independent broker, not a single carrier’s sales arm, which means the goal is finding the insurer whose underwriting appetite actually fits your MS history, rather than pushing one company’s product regardless of fit.

 

[


East Two West

 

A consultation starts with a plain conversation about your diagnosis timeline, EDSS status, and treatment history, then moves into gathering the records that matter most, your APS, MRI reports, and medication list, before anything gets submitted to a carrier. That groundwork is what lets an independent broker pre-shop your case across multiple carriers and avoid the trap of racking up formal declines while you search for the right fit. Whether you end up with a fully underwritten term policy, a simplified-issue product, or a guaranteed-issue plan as a stopgap, the strategy gets built around your actual medical picture, not a generic template. Request a quote or consultation to start the conversation.

 

This article is general information, not a substitute for advice from a qualified financial advisor. Consult a qualified financial professional about your own circumstances before acting on anything here.

 

Sources

 

 

FAQ

 

Can Someone With MS Get Approved for Life Insurance?

 

Yes, most people with MS can get approved, though pricing and speed depend heavily on EDSS score, time since the last relapse, and treatment consistency. Stable cases with minimal disability often qualify for standard or lightly rated term policies, while more active or progressive cases may need simplified-issue or guaranteed-issue coverage instead.

 

What Conditions Typically Disqualify You From Life Insurance?

 

No single diagnosis automatically disqualifies you, but severe, rapidly progressing conditions with significant functional decline and minimal documented stability make approval harder. Insurers look at the full picture, including relapse frequency, mobility limitations, and treatment response, rather than declining based on a diagnosis label alone.

 

Is It Possible to Live a Normal Life With MS?

 

Many people with MS, particularly relapsing-remitting cases managed with disease-modifying therapy, maintain long stretches of stability and full functional ability. That same stability is exactly what underwriters look for when pricing a life insurance application, which is part of why timing your application around documented stable periods matters so much.

 

What Type of Health Insurance Works Best for People With MS?

 

Health insurance and life insurance are evaluated separately, but for health coverage, plans with strong prescription drug formularies covering disease-modifying therapies and low specialist copays tend to serve MS patients best. Employer-sponsored plans and ACA marketplace plans with lower out-of-pocket maximums are worth comparing closely given how expensive MS medications can run.

 

How Long Should You Wait After a Relapse to Apply for Life Insurance?

 

There’s no universal guarantee, but carrier underwriting patterns show that applications within two years of an attack are frequently postponed, while cases further out often see improved rating tiers. Waiting until your neurologist confirms sustained stability, rather than applying immediately after a flare or medication change, generally leads to a better outcome.

Recommended

 

 
 
 

Comments


bottom of page